Latest news
Atara Biotherapeutics (NASDAQ:ATRA): What Could Today’s Update Reveal About Program Focus And Funding Discipline? - Kalkine MediaKalkine Media · Mon, 10 Aug 2026 08:55:00 GMTATRA DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Reminds - The National Law ReviewThe National Law Review · Sat, 08 Aug 2026 18:31:13 GMTAtara Biotherapeutics Inc (ATRA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKeyTradingKey · Fri, 07 Aug 2026 15:01:19 GMTATRA Q2'26 Earnings: EPS estimate is (0.32) USD - TradingViewTradingView · Fri, 07 Aug 2026 11:00:31 GMTUnderstanding Momentum Shifts in (ATRA) - Stock Traders DailyStock Traders Daily · Tue, 04 Aug 2026 17:50:01 GMTETFs Investing in Atara Biotherapeutics Inc Stocks - TradingViewTradingView · Sat, 01 Aug 2026 07:48:07 GMTEnterprise value to revenue forward of Atara Biotherapeutics, Inc. – NASDAQ:ATRA - TradingViewTradingView · Sat, 01 Aug 2026 04:15:31 GMTATRA|Atara Biotherapeutics Inc|Price:8.520|Chg%:+0.140 - TradingKeyTradingKey · Fri, 31 Jul 2026 07:00:00 GMT